Wells Messersmith, MD
University of Colorado, Denver · Anschutz Cancer Pavilion · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wells Messersmith, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05167409 · Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal CancerUniversity of Colorado, Denver · terminated · Microsatellite Stable Metastatic Colorectal Cancer · principal investigator
- Ph3NCT03781154 · Predictors of Physical Activity Maintenance in Colorectal Cancer SurvivorsUniversity of Colorado, Denver · completed · Colorectal Cancer · principal investigator
- Ph2NCT03542877 · Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal CancerAcademic Thoracic Oncology Medical Investigators Consortium · completed · Colorectal Cancer · principal investigator
- Ph2NCT03038477 · A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical ResectionUniversity of Colorado, Denver · withdrawn · Pancreatic Cancer · principal investigator
- N/ANCT02955446 · Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor MalignanciesUniversity of Colorado, Denver · no longer available · Neoplasm, Desmoid Tumor · principal investigator
- Ph2NCT02723331 · Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular CorrelatesAcademic Thoracic Oncology Medical Investigators Consortium · completed · Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma · principal investigator
- Ph3NCT01360853 · Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic CancerTraws Pharma, Inc. · completed · Metastatic Pancreatic Adenocarcinoma · study chair
- Ph1/Ph2NCT00816777 · Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal CancerGeneric Devices Consulting, Inc. · terminated · Unresectable Metastatic Colo-rectal Cancer · principal investigator
- Ph2NCT00303927 · Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase GeneSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Pancreatic Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Chemical and Structural BiologyP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI James M. Berger · fiscal years 2013 to 2026Named on NCT00303927
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.